B. Braun Medical launches next-generation OnGuard 2 CSTD
December 3, 2021 – B. Braun Medical Inc. announced that the OnGuard 2 CSTD is now available in the United States. OnGuard 2 incorporates all…
JHC’s Dail-eNews
BD acquires Venclose, Inc. to extend treatment innovations in chronic venous disease
December 2, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) has acquired Venclose, Inc., a provider of solutions for the treatment of chronic…
Thermo Fisher Scientific, Color Health launch K-12 ReadyCheckGo COVID-19 testing solution for Texas schools
December 2, 2021 – Thermo Fisher Scientific and Color Health, a health technology company committed to advancing public health, have launched a significant expansion of…
Amazon’s AWS helps Pfizer accelerate drug development and clinical manufacturing
December 2, 2021 – Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced it is working with Pfizer to create innovative, cloud-based solutions with…
CVS Health announces strategic alliance with Microsoft to accelerate digital transformation
December 2, 2021 – CVS Health and Microsoft Corp. announced a new strategic alliance focused on developing innovative solutions to help consumers improve their health…
Sri Trang USA hires Erica Halligan as Director – Health Systems
December 1, 2021 – Sri Trang USA announced it has hired Erica Halligan as director – health systems. Halligan previously was working to prevent contamination…
Roche completes purchase agreement with TIB Molbiol to expand PCR-test portfolio
December 1, 2021 – Roche (Basel, Switzerland) announced it has completed its share purchase agreement to acquire 100% of the outstanding shares of TIB Molbiol…
Queen’s Medical Center announces $1B campus modernization project
December 1, 2021 – Queen’s Medical Center (Hawaii) announced plans for a $1 billion, 15-year campus modernization project. The $85 million project will more than double the…
Quidel says it’s PCR, rapid antigen tests can detect Covid-19 Omicron variant
December 1, 2021 – Quidel Corporation issued the following statement from Douglas Bryant, Quidel’s President and CEO, regarding Quidel’s ongoing efforts to evaluate COVID-19 mutations…
Merck’s antiviral drug being considered by the FDA
December 1, 2021 – According to The Washington Post, advisers to the Food and Drug Administration are meeting to discuss the potential benefits and risks of Merck’s…